Brian C. Broderick’s Thermo Fisher Scientific TMO Stock Holding History

Brian C. Broderick’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$445K	Buy	905 +20	+2%	+$10.9K	0.08%	78
2025 Q4	$513K	Hold	885	–	–	0.1%	67
2025 Q3	$429K	Hold	885	–	–	0.08%	72
2025 Q2	$359K	Hold	885	–	–	0.07%	75
2025 Q1	$440K	Hold	885	–	–	0.09%	71
2024 Q4	$460K	Hold	885	–	–	0.09%	67
2024 Q3	$547K	Sell	885 -75	-8%	-$44.4K	0.11%	65
2024 Q2	$531K	Sell	960 -20	-2%	-$11.5K	0.11%	66
2024 Q1	$570K	Hold	980	–	–	0.12%	67
2023 Q4	$520K	Hold	980	–	–	0.13%	59
2023 Q3	$496K	Hold	980	–	–	0.14%	60
2023 Q2	$511K	Hold	980	–	–	0.13%	58
2023 Q1	$565K	Sell	980 -95	-9%	-$53.5K	0.16%	57
2022 Q4	$592K	Hold	1,075	–	–	0.18%	58
2022 Q3	$545K	Hold	1,075	–	–	0.17%	55
2022 Q2	$584K	Hold	1,075	–	–	0.18%	56
2022 Q1	$635K	Hold	1,075	–	–	0.16%	57
2021 Q4	$717K	Sell	1,075 -10	-0.9%	-$6.24K	0.17%	55
2021 Q3	$620K	Sell	1,085 -10	-0.9%	-$5.49K	0.17%	59
2021 Q2	$552K	Hold	1,095	–	–	0.15%	59
2021 Q1	$500K	Hold	1,095	–	–	0.14%	59
2020 Q4	$510K	Hold	1,095	–	–	0.15%	57
2020 Q3	$483K	Hold	1,095	–	–	0.15%	62
2020 Q2	$397K	Hold	1,095	–	–	0.13%	66
2020 Q1	$310K	Sell	1,095 -40	-4%	-$12.6K	0.12%	67
2019 Q4	$369K	Hold	1,135	–	–	0.12%	68
2019 Q3	$331K	Hold	1,135	–	–	0.11%	69
2019 Q2	$333K	Sell	1,135 -21	-2%	-$5.78K	0.12%	69
2019 Q1	$317K	Hold	1,156	–	–	0.11%	66
2018 Q4	$259K	Hold	1,156	–	–	0.11%	72
2018 Q3	$282K	Sell	1,156 -25	-2%	-$5.75K	0.1%	75
2018 Q2	$244K	Hold	1,181	–	–	0.09%	78
2018 Q1	$243K	Sell	1,181 -50	-4%	-$10.5K	0.09%	82
2017 Q4	$233K	Sell	1,231 -750	-38%	-$144K	0.09%	82
2017 Q3	$375K	Sell	1,981 -150	-7%	-$27.2K	0.14%	76
2017 Q2	$372K	Hold	2,131	–	–	0.14%	78
2017 Q1	$328K	Sell	2,131 -422	-17%	-$64.5K	0.13%	78
2016 Q4	$360K	Sell	2,553 -100	-4%	-$14.7K	0.16%	77
2016 Q3	$422K	Hold	2,653	–	–	0.18%	75
2016 Q2	$392K	Sell	2,653 -250	-9%	-$36.9K	0.16%	80
2016 Q1	$411K	Sell	2,903 -100	-3%	-$13.4K	0.18%	80
2015 Q4	$426K	Buy	3,003 +400	+15%	+$53.4K	0.19%	77
2015 Q3	$318K	Hold	2,603	–	–	0.15%	79
2015 Q2	$337K	Hold	2,603	–	–	0.14%	81
2015 Q1	$350K	Sell	2,603 -200	-7%	-$25.8K	0.15%	80
2014 Q4	$352K	Hold	2,803	–	–	0.15%	81
2014 Q3	$341K	Buy	+2,803	New	+$341K	0.15%	85

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Brian C. Broderick's TMO Position: Q1 2026 in Review

Brian C. Broderick increased its Thermo Fisher Scientific (TMO) stake by 2.3% in Q1 2026, buying an estimated $10.9K and bringing the position to 905 shares worth $445K. The position accounts for 0.08% of the portfolio, ranked #78.

Brian C. Broderick first reported a position in TMO in Q3 2014 and has held it in 47 quarters since. The position peaked at $717K in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Brian C. Broderick held 905 shares of Thermo Fisher Scientific worth $445K as of Q1 2026.
Brian C. Broderick bought 20 Thermo Fisher Scientific shares in Q1 2026, an estimated $10.9K.
Thermo Fisher Scientific made up 0.08% of Brian C. Broderick's portfolio in Q1 2026, its #78 holding.
Brian C. Broderick first reported a position in Thermo Fisher Scientific in Q3 2014 and has held it in 47 quarters since.
Brian C. Broderick's Thermo Fisher Scientific position peaked at $717K in Q4 2021.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Brian C. Broderick's 13F filing for Q1 2026, filed 7 May 2026.